Rethinking Clinical Trials

FEBRUARY 16, 2023

                                           Speakers Pearl O’Rourke, MD (retired) Harvard Medical School David S. Think about methods of notification, from detailed study-specific information to a general statement that research is being conducted. The study had a waiver of informed consent.

Clinical Trials 130

Clinical Trials Clinical Trials Medicine Trials 130

STAT News

MARCH 10, 2023

Enjoy, and see you soon … By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products , STAT explains.  Two

Insulin 96

Insulin Pharmacy Pharma Companies Drugs 96

Rethinking Clinical Trials

NOVEMBER 1, 2022

Duke Clinical Research Institute. Vanderbilt University Medical Center. On March 21, 2020, in response to the COVID-19 pandemic, PCORI contacted leadership at Duke Clinical Research Institute and PCORnet and a decision was made to focus on the space of healthcare workers. Emily O’Brien, PhD, FAHA. Associate Professor.

Trials 130

Trials Clinical Research Vaccination Vaccine 130

pharmaphorum

APRIL 26, 2021

The goal of the partnership for approval for the Japanese market from the Pharmaceuticals and Medical Devices Agency (PMDA). Jolly Good is a medical technology company that develops VR solutions and AI-based medical and welfare services that analyse user behaviour in the VR space.

Development 122

Development Medicine Production Marketing 122

Rethinking Clinical Trials

JULY 13, 2023

There were substantial improvements in the intervention group of the pilot study and improved guideline medical therapy that indicated that the virtual nudge strategy might be beneficial and scalable to multiple entities within an integrated healthcare system.    Speaker Ankeet S.

Clinical Trials 130

Clinical Trials Clinical Trials Scientist Research 130

Rethinking Clinical Trials

JANUARY 19, 2023

One definition of vulnerability is “an identifiably increased likelihood of incurring additional or greater wrongs,” as a result of research participation. We need to ask how might researchers wrong participants, and one way to think about this is how might researchers fail to discharge duties to them?

Trials 130

Trials Clinical Trials Clinical Trials Research 130

Rethinking Clinical Trials

SEPTEMBER 13, 2023

DEVICE, part of the Pragmatic Critical Care Research Group, was a multicenter, parallel-group, unblinded pragmatic, randomized trial compared the use of a video laryngoscope with the use of a direct laryngoscope for tracheal intubation of critically ill adults at 17 EDs and ICUs across U.S.

Trials 141

Trials Clinical Trials Clinical Trials Medicine 141

Rethinking Clinical Trials

FEBRUARY 9, 2023

This trial tested the hypothesis that the use of a platform-agnostic, EHR-embedded VTE risk model with integrated CDS would 1) increase rates of appropriate Thromboprophylaxis, and subsequently 2) reduce thromboembolism, compared to usual medical care in hospitalized, medically-ill patients.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Rethinking Clinical Trials

OCTOBER 26, 2023

point of care diagnostic tests, provide broad access to curative Hepatitis C medications with a national subscription model, with Medicare co-pay assistance and commercial insurance coverage. with the rate of reported acute Hepatitis C cases increasing 400% during 2010-2020. Rates are the highest among 20-39-year-olds.

Clinical Research 141

Clinical Research Clinical Trials Clinical Trials Research 141

BioTech 365

SEPTEMBER 25, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: RAP tag: A new protein purification approach.Whether it’s our diets, building strength, or as part of medical advancements, it is no secret that proteins form an important … Continue reading →

Protein 40

Protein Research 40

Rethinking Clinical Trials

NOVEMBER 16, 2022

University of Michigan Medical School. As one of the federal departments and agencies with the largest research and development budget, the NIH came out with one of the first federal data sharing policies in 2003 called the NIH Data Sharing Policy and Implementation Guidance. Assistant Professor of Obstetrics & Gynecology.

Clinical Trials 246

Clinical Trials Clinical Trials Trials Research 246

Rethinking Clinical Trials

MAY 10, 2023

Denny, MD, MS CEO, All of Us Research Program Slides Keywords Precision Medicine, All of Us Research Program Key Points The mission of the All of Us Research Program is to accelerate health research and medical breakthroughs, enabling individualized prevention, treatment, and care for all of us. .;

Medicine 130

Medicine Research Clinical Trials Clinical Trials 130

Rethinking Clinical Trials

JANUARY 17, 2024

Any patient admitted to the hospital with COVID-19 completed a COVID intake form in their admission record, and if they opted to learn about experimental therapies, a FaceTime call was set up with a research coordinator.          Speaker Erin K. The first drug that used the new process was Remdesivir in May 2020.

Clinical Trials 169

Clinical Trials Clinical Trials Antibody Trials 169

Intouch Solutions

NOVEMBER 30, 2021

blue links) of the organic results appeared to be pulling from content outside of the HTML title tag at a much higher frequency. URLs Examined: 860 URLs across 50 websites were examined; only URLs with all available data points were part of this research. Specifically, title links (i.e., Our Methodology. Considerations.

Branding 52

Branding Engineer Research Marketing 52

Rethinking Clinical Trials

JUNE 29, 2022

Office of Medical Policy (OMP). Center for Drug Evaluation and Research (CDER). Terminology is important in research work, and we should strive to be as precise as possible with the terminology we use. ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?. Speaker. John Concato, MD, MS, MPH. Food and Drug Administration (FDA).

Big Data 130

Big Data Clinical Trials Clinical Trials Drugs 130

Rethinking Clinical Trials

FEBRUARY 7, 2024

Food and Drug Administration (FDA) Commissioner Robert Califf asked the Reagan-Udall Foundation to conduct research and consult with experts to better understand how consumers find, consume, and perceive health information, especially regarding FDA-regulated products.

Regulation 152

Regulation Production Clinical Trials Clinical Trials 152

Rethinking Clinical Trials

JANUARY 31, 2024

Learn more Health AI Partnership Duke Institute for Health Innovation Discussion Themes -Can you talk about how DIHI/Health AI Partnership go about with the challenges in medical AI adoption outside of academic medical centers? There is a massive inequity and teams like DIHI are very rare.

Production 161

Production Development Clinical Trials Clinical Trials 161

Rethinking Clinical Trials

JULY 27, 2022

Vice Dean for Clinical Research. ACTIV-6 is testing medication doses approved by the FDA for other purposes, i.e., repurposed drugs. There is no observed symptomatic or clinical benefit of this medication of this dose or duration. ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?. Speaker.

Trials 169

Trials Pharmacy Medicine Clinical Trials 169

Rethinking Clinical Trials

JANUARY 9, 2024

Less work focuses on cluster level missingness, where the outcome is missing for an entire cluster of individuals, but researchers have made some progress in analyzing these cases. This research addresses two challenges – outcomes can be missing, and data for individuals within the same cluster are likely to be correlated.

Trials 275

Trials Clinical Trials Clinical Trials Research 275

Rethinking Clinical Trials

AUGUST 22, 2022

Core Faculty, Program for Health Disparities Research. University of Minnesota Medical School. Some aspects were a success, particularly delivery of study medication nation-wide within 1 day of consent. None of the medications appeared to have any effects on symptoms. Core Faculty, Center for Pediatric Obesity Medicine.

Trials 130

Trials Clinical Trials Clinical Trials Insulin 130

Rethinking Clinical Trials

FEBRUARY 28, 2024

            Speakers Adrian Hernandez, MD Executive Director, Duke Clinical Research Institute Vice Dean, Duke University School of Medicine Christopher J. Solutions include a bi-directional EDC (electronic data capture system), MyChart for research, and active notifications to study personnel based on entered data.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Clinical Research 141

Rethinking Clinical Trials

OCTOBER 18, 2023

The World Health Organization defines social determinants of health as non-medical factors that influence health outcomes and conditions in which people are born, grow, work, live, and age, and the wider set of forces and systems shaping the conditions of daily life.

Clinical Trials 117

Clinical Trials Clinical Trials Clinical Research Research 117

Rethinking Clinical Trials

MARCH 28, 2023

                                           Speakers Erin Holve, PhD, MPH, MPP Chief Research Infrastructure Officer, Patient-Centered Outcomes Research Institute (PCORI) Russell Rothman. has 8 clinical research networks across the country. enabled research. Every PCORnet®.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Rethinking Clinical Trials

MARCH 6, 2024

Medically tailored meals is the alternative. How much food to give is a parameter that needs more research. From a researcher standpoint, we need more information. The study did find substantial effects on diet and healthcare engagement. Learn more Read more in JAMA. Discussion Themes -Why do you think it was a negative study?

Clinical Trials 141

Clinical Trials Clinical Trials Medicine Trials 141

Rethinking Clinical Trials

JULY 9, 2023

Clinical research can exacerbate disparities, because clinical trials typically are based in urban, academic medical centers, underrepresent diverse populations, and overlook community engagement strategies in trial planning and design.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Rethinking Clinical Trials

FEBRUARY 14, 2024

We did the study at 72 medical centers and encountered 72 different themes within the EHR. When people understood what we were trying to do, embed research into clinical care, people really engaged and a few regional directors made participation one of the drivers of research in their region and helped us get initial groundwork.

Clinical Trials 152

Clinical Trials Clinical Trials Cardiology Trials 152

Rethinking Clinical Trials

OCTOBER 27, 2022

Duke Clinical Research Institute. Chief Research Technology Strategist. ePatient and Security Researcher. Patients use the internet to search for answers, and researchers use the internet to search for new solutions. Researchers need to overcome the risks of online tools and increase the benefits. Andrea Downing.

Clinical Research 130

Clinical Research Research Clinical Trials Clinical Trials 130

Rethinking Clinical Trials

MAY 19, 2023

It is difficult to enter and create visualizations of this data in the electronic health record (EHR), so the research team developed an EHR data visualization of home blood pressure from data entered via the patient portal. The primary outcome is blood pressure at 6 months. You can access the portal from desktop and phones.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

Rethinking Clinical Trials

AUGUST 30, 2023

There are 4 components to the treat-to-target approach: record disease activity using a composite measure every 3 months; specify disease activity target; adjust medications to target; and document shared decision making. There are new medications now that were not showing up that required regular updates to the dashboard.

Trials 141

Trials Clinical Research Coordinator Medicine Clinical Trials 141

pharmaphorum

OCTOBER 3, 2022

Chief medical officer at the independent drug pricing watchdog, Institute for Clinical and Economic Review (ICER), David Rind said Relyvrio should have been priced closer to the cost of production until there is clear proof about its efficacy. The post Amylyx ALS drug draws criticism over $158,000 price tag appeared first on.

Drugs 52

Drugs Generic Drugs FDA Approval Trials 52

Rethinking Clinical Trials

MARCH 15, 2023

An estimand is a precise description of the treatment effect that a researcher aims to estimate from the trial. An example of this is when patients experience better outcomes in a large hospital compared to a small hospital when given the same medication. and “How much would standard errors really change?”

Trials 130

Trials Clinical Trials Clinical Trials Research 130

Rethinking Clinical Trials

DECEMBER 6, 2022

Director, Cardiovascular and Metabolism Research, DCRI. Medication adherence can be a barrier to effectiveness. The focus of the study was on physical activity and medication adherence. Adherence to medical therapy was not measurably different between the arms. Professor of Medicine. Key Points. pctGR, @Collaboratory1.

Trials 130

Trials Clinical Trials Clinical Trials Compliance 130

Drug Discovery World

JANUARY 9, 2023

In this early research, Khalid Shah, Professor of Neurosurgery at Harvard Medical School and Brigham and Women’s Hospital, and colleagues tested the vaccine in an advanced mouse model of brain cancer glioblastoma, with promising results. “Our

Scientist 52

Scientist Gene Editing Gene Engineer 52

Rethinking Clinical Trials

AUGUST 18, 2022

Vanderbilt University Medical Center. The racism built into these categories does not go away when we do research. There are barriers at the health care professional and researcher level. The recruitment plan needs to include study materials that are tailored and accessible to the research population. Consuelo H.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Insulin 130

Rethinking Clinical Trials

DECEMBER 12, 2023

The research question Jumpstart set out to answer is can a patient-specific, clinician-facing communication priming intervention with discussion prompts effectively promote goals of care discussions between clinicians and hospitalized older adults with serious illness? It is something we are thinking about a lot in the outpatient trial.

Trials 130

Trials Medicine Clinical Trials Clinical Trials 130

Drug Discovery World

NOVEMBER 28, 2023

The peer-reviewed article titled ‘Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease (PD) mouse model’ was the result of collaborative work between Cambridge University, Harvard Medical School, and Mission Therapeutics. By inhibiting USP30, MTX325 helps restore normal mitophagy and thus cellular health.

In-Vivo 52

In-Vivo Protein Drugs Research 52

World of DTC Marketing

SEPTEMBER 9, 2021

for professional services, hospitalizations, medical supplies, and drugs. A study put a price tag on American’s bad eating habits: $50 billion a year in health care costs, attributable to cardiometabolic diseases such as heart disease, stroke, and type 2 diabetes. healthcare spending will reach $6.2 healthcare.

Drugs 222

Drugs Pharmacy Clinical Trials Clinical Trials 222